A detailed history of Mitchell Mcleod Pugh & Williams Inc transactions in Pfizer Inc stock. As of the latest transaction made, Mitchell Mcleod Pugh & Williams Inc holds 32,640 shares of PFE stock, worth $933,830. This represents 0.21% of its overall portfolio holdings.

Number of Shares
32,640
Previous 32,604 0.11%
Holding current value
$933,830
Previous $904,000 1.0%
% of portfolio
0.21%
Previous 0.22%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$25.26 - $29.6 $909 - $1,065
36 Added 0.11%
32,640 $913,000
Q1 2024

May 01, 2024

SELL
$25.89 - $29.73 $17,009 - $19,532
-657 Reduced 1.98%
32,604 $904,000
Q4 2023

Feb 05, 2024

SELL
$26.13 - $33.94 $46,955 - $60,990
-1,797 Reduced 5.13%
33,261 $957,000
Q3 2023

Oct 20, 2023

BUY
$32.09 - $37.51 $513 - $600
16 Added 0.05%
35,058 $1.16 Million
Q2 2023

Aug 08, 2023

BUY
$36.12 - $41.79 $108 - $125
3 Added 0.01%
35,042 $1.29 Million
Q1 2023

May 10, 2023

BUY
$39.39 - $51.28 $3,269 - $4,256
83 Added 0.24%
35,039 $1.43 Million
Q4 2022

Feb 03, 2023

BUY
$41.75 - $54.5 $40,831 - $53,301
978 Added 2.88%
34,956 $1.79 Million
Q3 2022

Nov 07, 2022

BUY
$43.76 - $53.42 $9,714 - $11,859
222 Added 0.66%
33,978 $1.49 Million
Q2 2022

Nov 18, 2022

SELL
$46.53 - $55.17 $10,329 - $12,247
-222 Reduced 0.65%
33,756 $1.77 Million
Q2 2022

Jul 19, 2022

SELL
$46.53 - $55.17 $17,262 - $20,468
-371 Reduced 1.09%
33,756 $1.77 Million
Q1 2022

Apr 26, 2022

BUY
$45.75 - $56.69 $30,240 - $37,472
661 Added 1.98%
34,127 $1.77 Million
Q4 2021

Feb 02, 2022

BUY
$41.32 - $61.25 $20,660 - $30,625
500 Added 1.52%
33,466 $1.98 Million
Q2 2021

Nov 08, 2021

BUY
$35.91 - $40.68 $11,024 - $12,488
307 Added 0.94%
32,966 $1.29 Million
Q2 2021

Aug 03, 2021

BUY
$35.91 - $40.68 $17,955 - $20,340
500 Added 1.55%
32,659 $1.28 Million
Q1 2021

May 12, 2021

BUY
$33.49 - $37.77 $36,303 - $40,942
1,084 Added 3.49%
32,159 $1.17 Million
Q4 2020

Feb 08, 2021

SELL
$33.47 - $42.56 $535 - $680
-16 Reduced 0.05%
31,075 $1.14 Million
Q3 2020

Oct 27, 2020

BUY
$31.75 - $37.25 $59,848 - $70,216
1,885 Added 6.45%
31,091 $1.14 Million
Q2 2020

Jul 17, 2020

BUY
$30.12 - $36.54 $361,530 - $438,589
12,003 Added 69.77%
29,206 $955,000
Q1 2020

Apr 08, 2020

SELL
$27.03 - $38.62 $113,282 - $161,856
-4,191 Reduced 19.59%
17,203 $562,000
Q4 2019

Jan 08, 2020

BUY
$32.92 - $37.36 $7,571 - $8,592
230 Added 1.09%
21,394 $838,000
Q3 2019

Oct 08, 2019

BUY
$32.49 - $42.13 $53,446 - $69,303
1,645 Added 8.43%
21,164 $760,000
Q2 2019

Jul 09, 2019

SELL
$36.98 - $41.52 $30,582 - $34,337
-827 Reduced 4.06%
19,519 $846,000
Q1 2019

Apr 11, 2019

BUY
$37.5 - $41.2 $46,200 - $50,758
1,232 Added 6.45%
20,346 $864,000
Q4 2018

Jan 10, 2019

BUY
$38.47 - $43.86 $4,231 - $4,824
110 Added 0.58%
19,114 $834,000
Q3 2018

Oct 09, 2018

SELL
$34.47 - $41.81 $448 - $543
-13 Reduced 0.07%
19,004 $838,000
Q2 2018

Jul 13, 2018

BUY
$32.98 - $35.16 $39,081 - $41,664
1,185 Added 6.65%
19,017 $690,000
Q1 2018

Apr 16, 2018

SELL
$31.91 - $37.02 $9,987 - $11,587
-313 Reduced 1.72%
17,832 $632,000
Q4 2017

Jan 12, 2018

BUY
$33.26 - $35.29 $10,410 - $11,045
313 Added 1.76%
18,145 $658,000
Q3 2017

Oct 12, 2017

BUY
$31.0 - $34.15 $552,792 - $608,962
17,832
17,832 $636,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $161B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Mitchell Mcleod Pugh & Williams Inc Portfolio

Follow Mitchell Mcleod Pugh & Williams Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitchell Mcleod Pugh & Williams Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mitchell Mcleod Pugh & Williams Inc with notifications on news.